CClinicalTrials.gg
CompletedNCT06071780VCOCLUpdated Oct 6, 2023

Virgin Coconut Oil Contact Lens as Ocular Rewetting Agent

An interventional study of organic product - Virgin Coconut Oil in Dry Eyes, sponsored by National University of Malaysia. Completed at 1 site in Malaysia. Open to participants aged 19 Years to 28 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-10-06.

Sponsored by National University of Malaysia · Not applicable, Interventional, and Diagnostic

From the registry’s dates

  • Registered 4 years 8 months after the study started (first participant enrolled Jan 2019, registered Sep 2023).
Phase
Not applicable
Study type
Interventional
Enrollment
44
Allocation
Randomized
Ages
19 Years to 28 Years
Sex
All
01

Study summary

This is a clinical trial where 44 subjects dry eyes were instilled with Virgin Coconut Oil (VCO CL) using contact lenses as its vehicle. All subjects are healthy subjects with no other ocular diseases except for having some dry eye symptoms (included with McMonnies questionnaires). Parameters measured at baseline and after 15 minutes of insertion and were compared. The control eyes were inserted with contact lenses soaked in saline (CCL). The eye that wears the VCO CL or the CCL were chosen randomly by masked operator. At the end of this study, the parameters measured will indicate if the VCO CL was able to retain tears in the eye and remove the dry eyes symptoms.

Read the detailed description

A new study using contact lens pre-soaked in virgin coconut oil (VCO CL) was conducted to determine the safety of the agent on dry eye human. Efficacy of the VCO CL was assessed by measuring TBUT, anterior eye assessment, corneal staining, pH, and Schirmer value and the measurement of residual VCO volume in tears before instillation (0 minute) and at 15 minutes after insertion. Wilcoxon Signed Rank and Mann Whitney U Test were used to analyse any changes in all the measurable variables. The differences of the TBUT, corneal staining and residual VCO volume in tears value in both eyes were analyzed. These study data will suggest if the VCO CL is safe and effective and can be recommended to be used as an option for dry eyes in human

02

Conditions studied

  • Dry Eyes

Keywords

  • Contact lens
  • VCO
  • TBUT
  • dry eyes
03

In context

Dry Eye Syndromes

1,292 studies on the registry are indexed under Dry Eye Syndromes; 191 are open to participants now.

This study's enrollment of 44 is below the median of 60 across 1,077 interventional studies indexed under Dry Eye Syndromes.

Browse Dry Eye Syndromes studies →

Lead sponsor

National University of Malaysia is the lead sponsor of 119 studies on the registry; 42 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
19 Years to 28 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Dry eye symptoms (according to McMonnies questionaires)
  • Written consent

Exclusion criteria

Exclusion Criteria:

  • No ocular diseases
  • No systemic diseases
  • Not wearing contact lenses regularly for the past 6 months
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
44 participants (actual)

Study arms

  • Active comparator
    VCO contact lens

    contact lens soaked in VCO

    Other: organic product - Virgin Coconut Oil

  • Placebo comparator
    control contact lens

    contact lens soaked in saline

    Other: organic product - Virgin Coconut Oil

Interventions

  • Otherorganic product - Virgin Coconut Oil

    A commercially available sterilized contact lens was soaked in VCO for 4 hours in a sterile condition to allow absorption of VCO into the contact lens polymer. The contact lens here is a vehicle to transport the VCO into the eye.

06

What researchers measure

Primary outcomes

  1. To compare the value of Tear Break-Up Time (TBUT) at baseline and 15 minutes after intervention

    This is to evaluate the 'oil' component in the tearfilm

    Time frame: 15 minutes

  2. To compare the value of Schimer's Test at baseline and 15 minutes after intervention

    This is to evaluate the aqueous component in the tear film

    Time frame: 15 minutes

  3. To compare the value of Corneal staining at baseline and 15 minutes after intervention

    Fluorescein staining will indicate dry spots

    Time frame: 15 minutes

  4. To measure the oil stained area after intervention and to compare it with the control group

    This oil stain will indicate the residual of VCO left in the eye after 15 minutes.

    Time frame: 15 minutes

07

Study locations

1 site
  • Optometry Clinic
    Kuala Lumpur, 50300, Malaysia
08

References and documents

Publications

  • Mutalib HA, Kaur S, Ghazali AR, Chinn Hooi N, Safie NH. A pilot study: the efficacy of virgin coconut oil as ocular rewetting agent on rabbit eyes. Evid Based Complement Alternat Med. 2015;2015:135987. doi: 10.1155/2015/135987. Epub 2015 Feb 23. PubMed 25802534 ↗

Study documents

  • Protocol, analysis plan and consent form · Aug 15, 2019

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Undecided — when requested will be considered

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 6, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06071780
Lead sponsor
National University of Malaysia
Responsible party
Assoc Prof Dr Haliza Abdul Mutalib (Assoc Prof Dr, National University of Malaysia) — Principal investigator
First posted
Oct 6, 2023
Start date
Jan 15, 2019
Primary completion
Dec 14, 2021
Completion
Mar 14, 2023
Last update
Oct 6, 2023

Study contacts

Haliza Abdul Mutalib, MOptom
principal investigator · National University of Malaysia

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion